Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Drugs. This report contains market size and forecasts of Ophthalmic Drugs in global, including the following market information:
Global Ophthalmic Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ophthalmic Drugs Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Ophthalmic Drugs companies in 2022 (%)
The global Ophthalmic Drugs market was valued at US$ 22950 million in 2022 and is projected to reach US$ 26720 million by 2029, at a CAGR of 2.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ophthalmic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Ophthalmic Drugs Market Segment Percentages, by Type, 2022 (%)
- Anti-allergy
- Anti-VEGF Agents
- Anti-inflammatory
- Anti-glaucoma
Global Ophthalmic Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Ophthalmic Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Clinic
- Pharmacy
Global Ophthalmic Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Ophthalmic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ophthalmic Drugs revenues share in global market, 2022 (%)
Key companies Ophthalmic Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Ophthalmic Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Santen Pharmaceutical
- Bausch Health
- Takeda
- Novartis
- Genentech
- Allergan
- Sun Pharmaceutical Industries
- Actavis Generics
- Regeneron Pharmaceuticals
- Pfizer
- Johnson and Johnson
- Bausch and Lomb
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Drugs, market overview.
Chapter 2: Global Ophthalmic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Ophthalmic Drugs Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Ophthalmic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmic Drugs Overall Market Size
2.1 Global Ophthalmic Drugs Market Size: 2022 VS 2029
2.2 Global Ophthalmic Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Ophthalmic Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Ophthalmic Drugs Players in Global Market
3.2 Top Global Ophthalmic Drugs Companies Ranked by Revenue
3.3 Global Ophthalmic Drugs Revenue by Companies
3.4 Global Ophthalmic Drugs Sales by Companies
3.5 Global Ophthalmic Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ophthalmic Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ophthalmic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ophthalmic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Ophthalmic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Ophthalmic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Ophthalmic Drugs Market Size Markets, 2022 & 2029
4.1.2 Anti-allergy
4.1.3 Anti-VEGF Agents
4.1.4 Anti-inflammatory
4.1.5 Anti-glaucoma
4.2 By Type - Global Ophthalmic Drugs Revenue & Forecasts
4.2.1 By Type - Global Ophthalmic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Ophthalmic Drugs Revenue, 2024-2029
4.2.3 By Type - Global Ophthalmic Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Ophthalmic Drugs Sales & Forecasts
4.3.1 By Type - Global Ophthalmic Drugs Sales, 2018-2023
4.3.2 By Type - Global Ophthalmic Drugs Sales, 2024-2029
4.3.3 By Type - Global Ophthalmic Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Ophthalmic Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ophthalmic Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacy
5.2 By Application - Global Ophthalmic Drugs Revenue & Forecasts
5.2.1 By Application - Global Ophthalmic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Ophthalmic Drugs Revenue, 2024-2029
5.2.3 By Application - Global Ophthalmic Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Ophthalmic Drugs Sales & Forecasts
5.3.1 By Application - Global Ophthalmic Drugs Sales, 2018-2023
5.3.2 By Application - Global Ophthalmic Drugs Sales, 2024-2029
5.3.3 By Application - Global Ophthalmic Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Ophthalmic Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Ophthalmic Drugs Market Size, 2022 & 2029
6.2 By Region - Global Ophthalmic Drugs Revenue & Forecasts
6.2.1 By Region - Global Ophthalmic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Ophthalmic Drugs Revenue, 2024-2029
6.2.3 By Region - Global Ophthalmic Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Ophthalmic Drugs Sales & Forecasts
6.3.1 By Region - Global Ophthalmic Drugs Sales, 2018-2023
6.3.2 By Region - Global Ophthalmic Drugs Sales, 2024-2029
6.3.3 By Region - Global Ophthalmic Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Ophthalmic Drugs Revenue, 2018-2029
6.4.2 By Country - North America Ophthalmic Drugs Sales, 2018-2029
6.4.3 US Ophthalmic Drugs Market Size, 2018-2029
6.4.4 Canada Ophthalmic Drugs Market Size, 2018-2029
6.4.5 Mexico Ophthalmic Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Ophthalmic Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Ophthalmic Drugs Sales, 2018-2029
6.5.3 Germany Ophthalmic Drugs Market Size, 2018-2029
6.5.4 France Ophthalmic Drugs Market Size, 2018-2029
6.5.5 U.K. Ophthalmic Drugs Market Size, 2018-2029
6.5.6 Italy Ophthalmic Drugs Market Size, 2018-2029
6.5.7 Russia Ophthalmic Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Ophthalmic Drugs Market Size, 2018-2029
6.5.9 Benelux Ophthalmic Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Ophthalmic Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Ophthalmic Drugs Sales, 2018-2029
6.6.3 China Ophthalmic Drugs Market Size, 2018-2029
6.6.4 Japan Ophthalmic Drugs Market Size, 2018-2029
6.6.5 South Korea Ophthalmic Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Ophthalmic Drugs Market Size, 2018-2029
6.6.7 India Ophthalmic Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Ophthalmic Drugs Revenue, 2018-2029
6.7.2 By Country - South America Ophthalmic Drugs Sales, 2018-2029
6.7.3 Brazil Ophthalmic Drugs Market Size, 2018-2029
6.7.4 Argentina Ophthalmic Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ophthalmic Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Ophthalmic Drugs Sales, 2018-2029
6.8.3 Turkey Ophthalmic Drugs Market Size, 2018-2029
6.8.4 Israel Ophthalmic Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Ophthalmic Drugs Market Size, 2018-2029
6.8.6 UAE Ophthalmic Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Santen Pharmaceutical
7.1.1 Santen Pharmaceutical Company Summary
7.1.2 Santen Pharmaceutical Business Overview
7.1.3 Santen Pharmaceutical Ophthalmic Drugs Major Product Offerings
7.1.4 Santen Pharmaceutical Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Santen Pharmaceutical Key News & Latest Developments
7.2 Bausch Health
7.2.1 Bausch Health Company Summary
7.2.2 Bausch Health Business Overview
7.2.3 Bausch Health Ophthalmic Drugs Major Product Offerings
7.2.4 Bausch Health Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Bausch Health Key News & Latest Developments
7.3 Takeda
7.3.1 Takeda Company Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Ophthalmic Drugs Major Product Offerings
7.3.4 Takeda Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Takeda Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Ophthalmic Drugs Major Product Offerings
7.4.4 Novartis Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Genentech
7.5.1 Genentech Company Summary
7.5.2 Genentech Business Overview
7.5.3 Genentech Ophthalmic Drugs Major Product Offerings
7.5.4 Genentech Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Genentech Key News & Latest Developments
7.6 Allergan
7.6.1 Allergan Company Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Ophthalmic Drugs Major Product Offerings
7.6.4 Allergan Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Allergan Key News & Latest Developments
7.7 Sun Pharmaceutical Industries
7.7.1 Sun Pharmaceutical Industries Company Summary
7.7.2 Sun Pharmaceutical Industries Business Overview
7.7.3 Sun Pharmaceutical Industries Ophthalmic Drugs Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.8 Actavis Generics
7.8.1 Actavis Generics Company Summary
7.8.2 Actavis Generics Business Overview
7.8.3 Actavis Generics Ophthalmic Drugs Major Product Offerings
7.8.4 Actavis Generics Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Actavis Generics Key News & Latest Developments
7.9 Regeneron Pharmaceuticals
7.9.1 Regeneron Pharmaceuticals Company Summary
7.9.2 Regeneron Pharmaceuticals Business Overview
7.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Major Product Offerings
7.9.4 Regeneron Pharmaceuticals Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Ophthalmic Drugs Major Product Offerings
7.10.4 Pfizer Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 Johnson and Johnson
7.11.1 Johnson and Johnson Company Summary
7.11.2 Johnson and Johnson Ophthalmic Drugs Business Overview
7.11.3 Johnson and Johnson Ophthalmic Drugs Major Product Offerings
7.11.4 Johnson and Johnson Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Johnson and Johnson Key News & Latest Developments
7.12 Bausch and Lomb
7.12.1 Bausch and Lomb Company Summary
7.12.2 Bausch and Lomb Ophthalmic Drugs Business Overview
7.12.3 Bausch and Lomb Ophthalmic Drugs Major Product Offerings
7.12.4 Bausch and Lomb Ophthalmic Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Bausch and Lomb Key News & Latest Developments
8 Global Ophthalmic Drugs Production Capacity, Analysis
8.1 Global Ophthalmic Drugs Production Capacity, 2018-2029
8.2 Ophthalmic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Ophthalmic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ophthalmic Drugs Supply Chain Analysis
10.1 Ophthalmic Drugs Industry Value Chain
10.2 Ophthalmic Drugs Upstream Market
10.3 Ophthalmic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ophthalmic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Ophthalmic Drugs in Global Market
Table 2. Top Ophthalmic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Ophthalmic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Ophthalmic Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Ophthalmic Drugs Sales by Companies, (K MT), 2018-2023
Table 6. Global Ophthalmic Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Ophthalmic Drugs Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Ophthalmic Drugs Product Type
Table 9. List of Global Tier 1 Ophthalmic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Ophthalmic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Ophthalmic Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Ophthalmic Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Ophthalmic Drugs Sales (K MT), 2018-2023
Table 15. By Type - Global Ophthalmic Drugs Sales (K MT), 2024-2029
Table 16. By Application - Global Ophthalmic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Ophthalmic Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Ophthalmic Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Ophthalmic Drugs Sales (K MT), 2018-2023
Table 20. By Application - Global Ophthalmic Drugs Sales (K MT), 2024-2029
Table 21. By Region - Global Ophthalmic Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Ophthalmic Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Ophthalmic Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Ophthalmic Drugs Sales (K MT), 2018-2023
Table 25. By Region - Global Ophthalmic Drugs Sales (K MT), 2024-2029
Table 26. By Country - North America Ophthalmic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Ophthalmic Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Ophthalmic Drugs Sales, (K MT), 2018-2023
Table 29. By Country - North America Ophthalmic Drugs Sales, (K MT), 2024-2029
Table 30. By Country - Europe Ophthalmic Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Ophthalmic Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Ophthalmic Drugs Sales, (K MT), 2018-2023
Table 33. By Country - Europe Ophthalmic Drugs Sales, (K MT), 2024-2029
Table 34. By Region - Asia Ophthalmic Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Ophthalmic Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Ophthalmic Drugs Sales, (K MT), 2018-2023
Table 37. By Region - Asia Ophthalmic Drugs Sales, (K MT), 2024-2029
Table 38. By Country - South America Ophthalmic Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Ophthalmic Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Ophthalmic Drugs Sales, (K MT), 2018-2023
Table 41. By Country - South America Ophthalmic Drugs Sales, (K MT), 2024-2029
Table 42. By Country - Middle East & Africa Ophthalmic Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Ophthalmic Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Ophthalmic Drugs Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Ophthalmic Drugs Sales, (K MT), 2024-2029
Table 46. Santen Pharmaceutical Company Summary
Table 47. Santen Pharmaceutical Ophthalmic Drugs Product Offerings
Table 48. Santen Pharmaceutical Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Santen Pharmaceutical Key News & Latest Developments
Table 50. Bausch Health Company Summary
Table 51. Bausch Health Ophthalmic Drugs Product Offerings
Table 52. Bausch Health Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Bausch Health Key News & Latest Developments
Table 54. Takeda Company Summary
Table 55. Takeda Ophthalmic Drugs Product Offerings
Table 56. Takeda Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Takeda Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Ophthalmic Drugs Product Offerings
Table 60. Novartis Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Genentech Company Summary
Table 63. Genentech Ophthalmic Drugs Product Offerings
Table 64. Genentech Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Genentech Key News & Latest Developments
Table 66. Allergan Company Summary
Table 67. Allergan Ophthalmic Drugs Product Offerings
Table 68. Allergan Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Allergan Key News & Latest Developments
Table 70. Sun Pharmaceutical Industries Company Summary
Table 71. Sun Pharmaceutical Industries Ophthalmic Drugs Product Offerings
Table 72. Sun Pharmaceutical Industries Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Sun Pharmaceutical Industries Key News & Latest Developments
Table 74. Actavis Generics Company Summary
Table 75. Actavis Generics Ophthalmic Drugs Product Offerings
Table 76. Actavis Generics Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. Actavis Generics Key News & Latest Developments
Table 78. Regeneron Pharmaceuticals Company Summary
Table 79. Regeneron Pharmaceuticals Ophthalmic Drugs Product Offerings
Table 80. Regeneron Pharmaceuticals Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Regeneron Pharmaceuticals Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Ophthalmic Drugs Product Offerings
Table 84. Pfizer Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. Pfizer Key News & Latest Developments
Table 86. Johnson and Johnson Company Summary
Table 87. Johnson and Johnson Ophthalmic Drugs Product Offerings
Table 88. Johnson and Johnson Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 89. Johnson and Johnson Key News & Latest Developments
Table 90. Bausch and Lomb Company Summary
Table 91. Bausch and Lomb Ophthalmic Drugs Product Offerings
Table 92. Bausch and Lomb Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 93. Bausch and Lomb Key News & Latest Developments
Table 94. Ophthalmic Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 95. Global Ophthalmic Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Ophthalmic Drugs Production by Region, 2018-2023 (K MT)
Table 97. Global Ophthalmic Drugs Production by Region, 2024-2029 (K MT)
Table 98. Ophthalmic Drugs Market Opportunities & Trends in Global Market
Table 99. Ophthalmic Drugs Market Drivers in Global Market
Table 100. Ophthalmic Drugs Market Restraints in Global Market
Table 101. Ophthalmic Drugs Raw Materials
Table 102. Ophthalmic Drugs Raw Materials Suppliers in Global Market
Table 103. Typical Ophthalmic Drugs Downstream
Table 104. Ophthalmic Drugs Downstream Clients in Global Market
Table 105. Ophthalmic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ophthalmic Drugs Segment by Type in 2022
Figure 2. Ophthalmic Drugs Segment by Application in 2022
Figure 3. Global Ophthalmic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ophthalmic Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Ophthalmic Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Ophthalmic Drugs Sales in Global Market: 2018-2029 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Ophthalmic Drugs Revenue in 2022
Figure 9. By Type - Global Ophthalmic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Ophthalmic Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Ophthalmic Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Ophthalmic Drugs Price (USD/MT), 2018-2029
Figure 13. By Application - Global Ophthalmic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Ophthalmic Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Ophthalmic Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Ophthalmic Drugs Price (USD/MT), 2018-2029
Figure 17. By Region - Global Ophthalmic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Ophthalmic Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Ophthalmic Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Ophthalmic Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Ophthalmic Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Ophthalmic Drugs Sales Market Share, 2018-2029
Figure 23. US Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Ophthalmic Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Ophthalmic Drugs Sales Market Share, 2018-2029
Figure 28. Germany Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Ophthalmic Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Ophthalmic Drugs Sales Market Share, 2018-2029
Figure 37. China Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Ophthalmic Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Ophthalmic Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Ophthalmic Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Ophthalmic Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Ophthalmic Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Ophthalmic Drugs Production Capacity (K MT), 2018-2029
Figure 53. The Percentage of Production Ophthalmic Drugs by Region, 2022 VS 2029
Figure 54. Ophthalmic Drugs Industry Value Chain
Figure 55. Marketing Channels
Global Artificial Tears Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 91
Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.
The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030.
The industry's leading producers are Aller......
Global Contact Lens Solution Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 96
Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard.
The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......
Global Latanoprost Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 82
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......
Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 99
Market Overview of Global Contact Lens Solution market:
According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......
Global Dry Eye Syndrome Drugs Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 82
The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive......
Global Eye Drops & Lubricants Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 112
According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period.
The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......
Global Conjunctivitis Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 98
According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period.
The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......
Global Contact Lens Solution Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 118
According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period.
The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......
Global Latanoprost Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 90
According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period.
The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
